In addition, FBXO5 exhibits a pro-proliferative effect in breast cancer tissues through PI3K/Akt signaling pathway, while PI3K inhibitor can reduce FBXO5 expression and arrest cell growth (11). This evidence concerns the gene AKT1 and breast cancer.